Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) EBIT (2016 - 2018)

Achieve Life Sciences (ACHV) has disclosed EBIT for 7 consecutive years, with -$3.6 million as the latest value for Q4 2018.

  • Quarterly EBIT rose 2.75% to -$3.6 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$12.7 million through Dec 2018, up 7.15% year-over-year, with the annual reading at -$16.4 million for FY2019, 29.23% down from the prior year.
  • EBIT for Q4 2018 was -$3.6 million at Achieve Life Sciences, down from -$3.2 million in the prior quarter.
  • The five-year high for EBIT was -$166000.0 in Q2 2017, with the low at -$9.4 million in Q3 2017.
  • Average EBIT over 4 years is -$2.6 million, with a median of -$2.8 million recorded in 2018.
  • The sharpest move saw EBIT plummeted 2220.99% in 2017, then soared 65.53% in 2018.
  • Achieve Life Sciences' EBIT stood at -$1.2 million in 2015, then surged by 50.36% to -$613000.0 in 2016, then tumbled by 510.11% to -$3.7 million in 2017, then rose by 2.75% to -$3.6 million in 2018.
  • Per Business Quant, the three most recent readings for ACHV's EBIT are -$3.6 million (Q4 2018), -$3.2 million (Q3 2018), and -$2.8 million (Q2 2018).